收藏切换
Evidence-based pharmacoeconomic evaluation of caspofungin in the treatment of elderly patients with invasive fungal infection
收藏切换
Xiaoju XU, Yue YOU, Ming CHEN, Guorong FAN*
World Clinical Drug | 2022, 43(1) : 62 - 69
Less
收藏切换
World Clinical Drug | 2022, 43(1): 62-69
• Article •
Evidence-based pharmacoeconomic evaluation of caspofungin in the treatment of elderly patients with invasive fungal infection
Full
Xiaoju XU, Yue YOU, Ming CHEN, Guorong FAN*
Affiliations
  • Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China
Published: 2022-01-10 doi: 10.13683/j.wph.2022.01.012
Outline
收藏切换
Objective

To systematically evaluate the effectiveness, safety and economy of capofungin in the treatment of elderly invasive fungal infection (IFI), and to provide evidence-based reference for clinical treatment.

Methods

Computer search of PubMed, Cochrane Library, Embase, CNKI, Chinese Journal Full-text Database, VIP and Wanfang Database, etc., collect randomized controlled trials (RCT) of caspofungin in the treatment of elderly IFI, and extract data from literature that meets the inclusion criteria. The modified Jadad scale was used to evaluate the quality of the included literature, the RevMan 5.3 software was used to conduct meta-analysis of the total clinical effectiveness and the incidence of adverse drug reactions, the cost-effectiveness analysis method was used to conduct economic evaluation, and the single-factor sensitivity analysis and Probability sensitivity analysis.

Results

A total of 6 RCTs were included, with a total of 551 patients. The results of meta-analysis showed that the total effective rate of patients in the experimental group (caspofungin group) was significantly higher than that of the control group (other drug groups), and the difference was statistically significant [OR=2.54, 95%CI(1.75, 3.69), P<0.001]; There was no significant difference in the incidence of adverse drug reactions between the two groups of patients [OR=0.43, 95%CI(0.16, 1.17), P=0.10]. The pharmacoeconomic evaluation results showed that caspofungin had the highest clinical effectiveness, but the cost is also higher. Caspofungin was always more economical than amphotericin B liposomes, and the increased cost relative to itraconazole, voriconazole and amphotericin B was also within an acceptable range.

Conclusion

Caspofungin is effective, safe and economical in the treatment of elderly IFI. However, this conclusion needs to be further verified by more large-sample, high-quality, multi-center RCTs.

caspofungin  /  invasive fungal infection  /  elderly patients  /  meta-analysis  /  pharmacoeconomics
徐小菊, 尤越, 陈明, 范国荣. 卡泊芬净治疗老年侵袭性真菌感染的循证药物经济学评价. 世界临床药物, 2022 , 43 (1) : 62 -69 . DOI: 10.13683/j.wph.2022.01.012
Xiaoju XU, Yue YOU, Ming CHEN, Guorong FAN. Evidence-based pharmacoeconomic evaluation of caspofungin in the treatment of elderly patients with invasive fungal infection[J]. World Clinical Drug, 2022 , 43 (1) : 62 -69 . DOI: 10.13683/j.wph.2022.01.012
Year 2022 volume 43 Issue 1
6
0
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.01.012
  • Receive Date:2021-09-07
  • Online Date:2026-11-19
  • Published:2022-01-10
Article Data
Affiliations
History
  • Received:2021-09-07
  • Revised:2021-12-16
Affiliations
    Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.01.012
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT